Fusion Antibodies PLC Ordinary Shares (FAB)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

10.00p

Buy

11.00p

arrow-up0.00p (+0.00%)

Prices updated at 05 Aug 2026, 15:29 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Fusion Antibodies PLC is a Contract Research Organisation (CRO) providing antibody identification, engineering, and expression services for the discovery and development of antibodies for human and veterinary therapeutics, as well as for diagnostics. ...
FTSE All-Share
arrow-up0.15%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
our Investment Fees and Charges.
Sector
Healthcare
Industry
Biotechnology
Chairman
Dr. Simon Gordon Douglas
CEO
Dr. Adrian Robert Kinkaid
Most recent earnings
31 Mar 2025
Fiscal year end
31 Mar 2025
Employees
18
Head office
1 Springbank Road
Belfast
United Kingdom
BT17 0QL
mobile
+44 2079338780
letter
info@fusionantibodies.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Dr. Simon Gordon Douglas
Non-Executive Director, Chairman
-
Mr. Colin James Walsh
Non-Executive Director
-
Mr. Matthew Paul Baker
Non-Executive Director
-
Dr. Richard John Buick
Executive Director, Chief Scientific Officer
-
Dr. Adrian Robert Kinkaid
Executive Director, Chief Executive Officer
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Unicorn Asset Management Ltd8,320,366
Unicorn AIM VCT Series 3 ORD8,320,366
Octopus Investments Limited590,164

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
17 Feb 2026Transfer out
30 Jan 2026Purchase
30 Jan 2026Purchase
30 Jan 2026Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.